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An enzymatic activity has been identified which is capable of generating a product chromatographically identical with 
adrenorphin from the model substrate BAM 12P. This enzyme was purified by gel filtration and ion-exchange chromatog- 
raphy and characterised as having a molecular mass between 30 and 45 kDa and an acidic pL The enzyme isactive at 
the acid pH expected inthe secretory vesicle interior and is inhibited by EDTA, suggesting that it is a metalloprotease. 
This activity could not be mimicked by incubation with lysosomal fractions and it meets the criteria to be considered 
as a possible prohormone processing enzyme. 
Prohormone processing; Adrenorphin; Secretory vesicle purification 
1. INTRODUCTION 
Active peptide hormones are released from their 
precursors by endoproteolytic cleavage at highly 
specific sites. The commonest of these is cleavage 
at pairs of basic residues such as lysine and 
arginine [1,2]. However another common class of 
processing sites are known to be at single arginine 
residues, adjacent o a proline [3]. It is thought 
that this type of cleavage might be important in 
tissue-specific cleavage patterns [3]. 
Adrenorphin,  a proenkephal in fragment, is 
derived by cleavage on the amino side of an 
arginine-prol ine sequence [4]. Adrenorphin is a 
highly active mu agonist [5] and is of interest since 
the ratio of this peptide to other proenkephal in 
fragments varies from one brain region to another 
[6] indicating tissue-specific processing. 
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The purif ication of an endopeptidase r sponsi- 
ble for the generation of adrenorphin was under- 
taken, using the ovine adrenal medulla s a source. 
Adrenorphin  is known to be located in the adrenal 
medul la of all species so far investigated [6]. 
Secretory vesicles (also known as chromaff in 
granules) were isolated as a prel iminary purifica- 
t ion step, since it is known that prohormone pro- 
cessing occurs within the secretory vesicle [1]. It is 
particularly important  that lysosomes be 
el iminated at this stage so that lysosomal proteases 
do not interfere with, or become confused with, 
the prohormone processing activity. 
2. MATERIALS  AND METHODS 
2.1. Subcellular fractionation 
Ovine adrenals were collected on ice and the medullas were 
dissected out and homogenised in isotonic buffer (10 mM 
Hepes, 0.25 M sucrose, pH 7.4). A vesicle pellet was isolated by 
differential centrifugation aspreviously described [7]. This was 
applied onto an isoosmolar Metrizamide gradient [8] with steps 
of 0.15, 0.28 and 0.45 M Metrizamide (see fig.I). Fractions 
were collected from the bottom of the tube with a peristaltic 
pump. The vesicle nriched fractions from this gradient (frac- 
tions 6 and 7 in fig.l) were then applied to a sucrose gradient 
with a 1.8 M sucrose cushion. The vesicles were collected as a 
pellet after centrifugation. Lysosome fractions were collected 
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Fig.l .  Purification of secretory vesicles on a Metrizamide 
gradient with steps of 0.45 M (I ml), 0.28 M (5 ml) and 0.15 M 
(2 ml). 1 ml fractions were collected from the bottom of the 
tube (therefore fraction 1 is the densest). The percentage 
distribution is shown within the gradient for protein (v),  ~'- 
glucuronidase as a lysosomal marker ( - )  and enkephalins and 
other opiate peptides detected by radioreceptor assay (o) as a 
marker for vesicles. 
2.2. Assays for sub-cellular fractions 
~'-Glucuronidase was assayed as a lysosomal marker by in- 
cubation with 4-methyl umbelliferol B-glucuronide and detec- 
tion of  the fluorescent leaving group [8]. Opiate peptides were 
assayed as a vesicle marker, using a radioreceptor assay [7]. 
Protein was assayed by the Lowry method [7]. 
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both from the Metrizamide gradient (fraction 2) and from the 
sucrose gradient (at the interface with the 1.8 M cushion). 
The vesicles were lysed by freezing and thawing in 10 mM 
Hepes, pH 7.4, and the vesicle contents eparated from the 
membranes by centrifugation at 10000 × g for 15 min. 
Table 1 
Purification of secretory vesicles 
Fraction % recovery % recovery Purification b 
of vesicles a of lysosomes a 
S1 c 78.0 + 6.0 49.9 _ 6.7 1.6 _+ 0.3 
P1 14.9 + 2.7 38.0 _+ 2.7 0.4 _-4- 0.08 
$2 38.0 + 3.2 23.6 + 3.8 1.7 +_ 0.3 
P2 33.6 ___ 2.6 23.3 + 5.6 1.6 _+ 0.5 
Band from 
Gradient 1 20.0 _+ 2.5 4.2 + 1.2 5.1 _+ 0.9 
Sucrose pellet 4.7 _+ 1.1 0.08 _+ 0.03 54 _+ 8 
a Calculated as a percentage of the amount in the homogenate 
(n = 5) 
b The ratio of the two markers in a fraction divided by the same 
ratio in the homogenate 
c PI ,  S1, P2, $2 refer to the differential centrifugation 
fractions 
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Fig.2. Reverse-phase HPLC separation of peptides. After an 
initial 30 min of  100070 buffer A, a linear gradient was run up 
to 40°70 buffer B in 30 min. Panel a shows a separation of 
[125I]adrenorphin and []251]BAMI2P. Panel b shows the 
separation of peptides after incubation of [~251]BAM12P with 
fraction l l  from gel filtration. The position of the following 
markers is shown: A, Met-enkephalin; B, adrenorphin and 
adrenorphin Gly9; C, [t251]adrenorphin a d [1251]adrenorphin 
Gly9; D, BAMI2P; E, [n2~I]BAM12P; F, dynorphin(1-6); G, 
dynorphin(1-7); H, Leu-enkephalin; 1, dynorphin(1-9); J, 
dynorphin( l -8);  P, expected product, [1251]adrenorphin; S, 
substrate, [125I]BAM12P. 
45 
FEBS LETTERS March 1989 Volume 246, number 1,2 
2.3. Enzyme activity incubations 
Fractions were incubated for 2 h at 37°C with 20000 cpm of 
[lzSI]BAM12P (iodinated by the Chloramine T method and 
purified by HPLC) in 0.1 M Mes, pH 6. Inhibitors were dissolv- 
ed in the same buffer. Phosphate and Tris were used as the buf- 
fers to determine pH optimum (5-7 and 6-8, respectively). 
After incubation, the reaction was stopped by addition of HCI 
to 0.1 M and an aliquot applied to an LKB Spherisorb ODS 
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Fig.3. Gel filtration of vesicle soluble fraction. The flow rate 
was 0.2 ml/min and 1 ml fractions were collected. Panel a, 
absorbance at223 nm. The position of molecular mass markers 
from a parallel run is shown: 66 kDa, bovine serum albumin; 
45 kDa, ovalbumin; 29 kDa, carbonic anhydrase; 20 kDa, 
trypsin inhibitor. Panel b shows incubations of the fractions 
with [1251]BAM12P. The amount of product generated by 
fraction 11 is set as a relative activity of 1.0. 
reverse-phase column. Buffers were 20o7o and 80o7o acetonitrile 
with 0.1% TFA. 
Gel filtration was conducted on an LKB TSK G3000SW col- 
umn in 0.1 M ammonium formate and ion exchange on an LKB 
TSK DEAE 5PW column with a gradient from 0 to 0.5 M NaC1 
in 10 mM Mes, pH 6. 
3. RESULTS 
Dens i ty -grad ient  cent r i fugat ion  on  a Met r i -  
zamide  dens i ty  grad ient  y ie lded a par t ia l ly  pure  
vesic le preparat ion  (fig. 1). Fur ther  pur i f i ca t ion  on  
a sucrose  cush ion  gave a pur i f i ca t ion  o f  vesicles 
over  lysosomes  o f  54- fo ld  compared  wi th  the 
in i t ia l  homogenate  (see tab le  1). 
E lu t ion  pos i t ions  for  the  mode l  subst ra te  
BAM12P and  the  expected  product ,  adrenorph in ,  
were es tab l i shed  on  HPLC (f ig.2).  Secretory  
vesic les were lysed and  the  membrane and  so lub le  
f rac t ions  incubated .  On ly  the  so lub le  f rac t ion  
generated  any  product .  
The  so lub le  f rac t ion  f rom the vesicles was fur -  
ther  pur i f ied  by  gel f i l t ra t ion  (f ig.3).  The  peak  o f  
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Fig.4. Ion-exchange chromatography of fraction l l  from gel 
filtration. The flow rate was 1 ml/min and 1 ml fractions were 
collected. Panel a shows absorbance at223 nm. Panel b shows 
the amount of product generated (setting fraction 21 as 1.0, see 
fig.3b). 
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Table 2 
Effect of inhibitors on enzyme activity 
Inhibitor a Conc. % of control b
PMSF 1.0 mM 51 
TLCK 1.0 mM 34 
PCMB 1.0 mM 23 
Aprotinin 0.1 mg/ml 30 
DTT 0.01 mM 92 
DTT 0.1 mM 46 
DTT 1.0 mM 37 
EDTA 1.0 mM 1 
EDTA and Co z+ 1.0 mM+ 1.5 mM 41 
EDTA and Mn 2÷ 1.0 mM+ 1.5 mM 44 
EDTA and Cu 2÷ 1.0 mM+ 1.5 mM 1 
EDTA and Ca 2÷ 1.0 mM + 1.5 mM 1 
a PMSF, phenylmethylsulphonyl fluoride; TLCK, tosyl-L- 
lysine-chloromethyl ketone; PCMB, p-chloromercuribenzoic 
acid; DTT, dithiothreitol 
b These values are the amount of product detected on HPLC as 
a percentage of that seen in a parallel incubation using the 
same enzyme preparation without inhibitors 
activity emerged in fraction 11, corresponding to a 
molecular mass of 45 kDa, predicted from a 
parallel run with standards. The soluble fraction 
from the lysosomal band, purified by Metrizamide 
density gradient and sucrose cushion, was also sub- 
jected to gel filtration. Aliquots from this separa- 
tion were then incubated with substrate. The size 
of the aliquots was calculated to contain the same 
amount of~'-glucuronidase activity (the marker en- 
zyme for lysosomes) as was found as a contami- 
nant in the vesicle preparation. These incubations 
did not generate any product, neither did incuba- 
tions with ten times larger amounts. 
Fraction 11 from gel filtration was further 
purified by ion-exchange chromatography (fig.4). 
The enzyme had a pH optimum of 7.8 but retained 
30% of its maximal activity at pH 6, and was most 
strongly inhibited by EDTA and DTT (table 2). 
4. DISCUSSION 
The vesicle purification protocol yielded such a 
high level of purification because of the successive 
isoosmolar and then hyperosmolar gradients. A 
previous study had revealed that ovine medullary 
vesicles hrink and become denser in hyperosmotic 
media to a greater extent than lysosomes [7]. 
Therefore this method first removes the densest 
lysosomes by isoosmolar separation and then in- 
creases the density of the vesicles in the second gra- 
dient so that they pellet leaving the remaining 
lysosomes behind. 
Cleavage of BAM12P might be expected to oc- 
cur between glycine and arginine in the sequence 
Val-Gly-Arg-Pro. An amidating enzyme could 
then convert the Val-Gly C-terminus to valine 
amide [9], although the levels of amidating enzyme 
are reported to be low in the adrenal [10]. The ac- 
tivity in this study generates a substance which co- 
chromatographs with adrenorphin. This may be 
adrenorphin generated directly or by a co- 
purifying amidating enzyme; however, the HPLC 
conditions chosen do not separate adrenorphin 
from adrenorphin Gly 9 and the latter seems the 
most likely product. It is clear that the product has 
an intact Tyr since it is radioactive with iodine-125 
and is larger than Met-enkephalin (from the 
available markers). Since the activity bound to an 
anion-exchange column at pH 6 it can be deduced 
to have a pI of less than 6. The inhibition by 
EDTA indicates a metalloprotease and that by 
DTT suggests the involvement of thiol groups. The 
partial inhibition by PMSF, TLCK and aprotinin, 
although at relatively high doses, presents a more 
complicated picture and will be investigated fur- 
ther with a full dose-response profile. 
Although crude lysosome preparations might be 
expected to cleave the substrate at multiple sites it 
remains possible that the isolation procedure 
selects a single lysosomal protease which has this 
activity. Therefore lysosomal material was sub- 
jected to the same purification and incubation pro- 
tocol as the vesicle material. However, no 
adrenorphin-like product was detected, strongly 
suggesting that this enzyme is vesicular ather than 
lysosomal. 
This activity does not generate significant 
amounts of Met-enkephalin under these condi- 
tions, indicating that it is different from the en- 
zymes described which cleave at pairs of basic 
residues in the adrenal [11]. This activity also dif- 
fers from prolyl endopeptidase, which is fully ac- 
tive in the presence of 1 mM EDTA [12]. This 
activity is similar to one described in the atrial 
gland of Aplysia californica [13] which cleaved 
dynorphin A at the amino side of arginine-proline 
sequences and was inhibited by EDTA. It may be 
that there is an evolutionary relationship between 
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the Aplysia prohormone process ing enzyme and 
the ov ine  act ivity.  
Fur ther  pur i f i cat ion  o f  this act iv i ty is now being 
under taken  in order  to raise ant ibodies  against the 
pure prote in  and study its d is t r ibut ion and 
regulat ion.  
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